Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma
Publication
, Journal Article
Schmidts, A; Ormhøj, M; Choi, BD; Taylor, AO; Bouffard, AA; Scarfò, I; Larson, RC; Frigault, MJ; Gallagher, K; Castano, AP; Riley, LS; Zhou, J ...
Published in: Blood Advances
November 12, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood Advances
DOI
EISSN
2473-9537
ISSN
2473-9529
Publication Date
November 12, 2019
Volume
3
Issue
21
Start / End Page
3248 / 3260
Publisher
American Society of Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schmidts, A., Ormhøj, M., Choi, B. D., Taylor, A. O., Bouffard, A. A., Scarfò, I., … Maus, M. V. (2019). Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances, 3(21), 3248–3260. https://doi.org/10.1182/bloodadvances.2019000703
Schmidts, Andrea, Maria Ormhøj, Bryan D. Choi, Allison O. Taylor, Amanda A. Bouffard, Irene Scarfò, Rebecca C. Larson, et al. “Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.” Blood Advances 3, no. 21 (November 12, 2019): 3248–60. https://doi.org/10.1182/bloodadvances.2019000703.
Schmidts A, Ormhøj M, Choi BD, Taylor AO, Bouffard AA, Scarfò I, et al. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances. 2019 Nov 12;3(21):3248–60.
Schmidts, Andrea, et al. “Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.” Blood Advances, vol. 3, no. 21, American Society of Hematology, Nov. 2019, pp. 3248–60. Crossref, doi:10.1182/bloodadvances.2019000703.
Schmidts A, Ormhøj M, Choi BD, Taylor AO, Bouffard AA, Scarfò I, Larson RC, Frigault MJ, Gallagher K, Castano AP, Riley LS, Cabral ML, Boroughs AC, Velasco Cárdenas RM-H, Schamel W, Zhou J, Mackay S, Tai Y-T, Anderson KC, Maus MV. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Advances. American Society of Hematology; 2019 Nov 12;3(21):3248–3260.
Published In
Blood Advances
DOI
EISSN
2473-9537
ISSN
2473-9529
Publication Date
November 12, 2019
Volume
3
Issue
21
Start / End Page
3248 / 3260
Publisher
American Society of Hematology